20 LATEST RESOURCES (215 INDEXED)
MDMA-Assisted Psychotherapy for PTSD: Growing Evidence for Memory Effects Mediating Treatment Efficacy · August 2023
Articles
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder and Early-Stage Dementia: The MEMORY Study · June 2023
Articles
Journal of Affective Disorders
Clinical Benefits of Vortioxetine 20 Mg/Day in Patients with Major Depressive Disorder · April 2023
Articles
CNS Spectrums
Effects of Adjunctive Brexpiprazole on Patient Life Engagement in Major Depressive Disorder: Post Hoc Analysis of Inventory of Depressive Symptomatology Self-Report Data · April 2023
Articles
Journal of Psychiatric Research
Clonidine Augmentation in Patients with Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial · March 2023
Articles
Schizophrenia Research
Long-Term Safety and Efficacy, Including Anhedonia, of Vortioxetine for Major Depressive Disorder: Findings from Two Open-Label Studies · March 2023
Articles
Current Medical Research and Opinion
Safety and Effectiveness of Vortioxetine for Major Depressive Disorder: Real-World Evidence from a Population-Based Study in South Korea · March 2023
Articles
Frontiers in Psychiatry
Vortioxetine in Patients with Major Depressive Disorder and High Levels of Anxiety Symptoms: An Updated Analysis of Efficacy and Tolerability · January 2023
Articles
Journal of Affective Disorders
Risk of Mania After Methylphenidate in Patients with Bipolar Disorder · January 2023
Abstracts
Journal of Clinical Psychopharmacology
Effectiveness of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: US Cohort Results from the Global RELIEVE Study · January 2023
Articles
Frontiers in Psychiatry
Haloperidol for the Treatment of Delirium in ICU Patients · December 2022
Articles
New England Journal of Medicine
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder and Co-Morbid Generalized Anxiety Disorder in Routine Clinical Practice: A Subgroup Analysis of the RELIEVE Study · November 2022
Articles
Journal of Psychopharmacology
Duloxetine Exposure during Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study · November 2022
Articles
Drugs – Real World Outcomes
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression · November 2022
Articles
New England Journal of Medicine
Use of Low-Dose Quetiapine Increases the Risk of Major Adverse Cardiovascular Events: Results from a Nationwide Active Comparator-Controlled Cohort Study · September 2022
Articles
World Psychiatry
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study · August 2022
Articles
Neurology and Therapy
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study · August 2022
Articles
Neuropsychiatric Disease and Treatment
The Prescriber’s Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression · July 2022
Articles
CNS Spectrums
Serious Arrhythmia in Initiators of Citalopram, Escitalopram, and Other Selective Serotonin Reuptake Inhibitors: A Population-Based Cohort Study in Older Adults · June 2022
Articles
Clinical and Translational Science
Investigation of the Potential Association between the Use of Fluoxetine and Occurrence of Acute Pancreatitis: A Danish Register-Based Cohort Study · April 2022
Articles
International Journal of Epidemiology